Gyre Therapeutics (GYRE) Treasury Shares (2011 - 2026)

Gyre Therapeutics (GYRE) has reported Treasury Shares for 11 consecutive years, with $13151.0 the latest figure, recorded in Q4 2023.

• In Q4 2023, Treasury Shares rose 6.57% year-over-year to $13151.0; the TTM figure through Dec 2023 stood at $13151.0 (up 6.57% YoY), while the FY2023 annual figure was $13151.0, up 6.57% from the prior year.
• Treasury Shares slipped to $13151.0 in Q4 2023 per GYRE's latest filing, from $37975.0 in the prior quarter.
• Across five years, Treasury Shares topped out at $1.6 million in Q2 2019 and bottomed at $12340.0 in Q4 2022.
• Historically, Treasury Shares has averaged $810543.8 across 3 years, with a median of $803906.5 in 2019.
• Annual changes were most pronounced in 2019 — Treasury Shares jumped 57.14% — and 2023, when it increased 6.57%.
• Gyre Therapeutics' Treasury Shares stood at $1.6 million in 2019, then slumped by 99.22% to $12340.0 in 2022, then climbed by 6.57% to $13151.0 in 2023.
• Business Quant data shows GYRE's Treasury Shares at $13151.0 in Q4 2023, $37975.0 in Q2 2023, and $12340.0 in Q1 2023.